- Market Capitalization, $K 306,787
- Shares Outstanding, K 175,307
- Annual Sales, $ 38,370 K
- Annual Income, $ -20,170 K
- 60-Month Beta 0.16
- Price/Sales 8.09
- Price/Cash Flow N/A
- Price/Book 8.78
|Period||Period Low||Period High||Performance|
| || |
+0.2500 (+16.56%)since 05/18/21
| || |
-0.5900 (-25.11%)since 03/18/21
| || |
+0.6700 (+61.47%)since 06/18/20
180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases,...
Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI or "Marrone Bio"), an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, has entered into...
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MBII, VFF, MOXC, LHDX, and KDMN.
Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of 0.00% and -0.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?...
Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released...
Marrone Bio Innovations, Inc. (NASDAQ: MBII) has provided its financial results for the first quarter ended March 31, 2021. Key results include:
NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Marrone Bio Innovations, Inc. (NASDAQ:MBII) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at...
The global biostimulants market size is expected to gain traction by reaching USD 5.35 billion by 2027. This information is published by Fortune Business Insights in its report, titled "Biostimulants Market,...
Marrone Bio Innovations, Inc. (MBII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable agricultural biological solutions, announced today that BIOSt Nematicide seed treatment product, achieved an outstanding...
|Marrone Bio Innov|
|Micro-Cap Ishares ETF|
|GS Activebeta U.S. Small Cap Equity ETF|
|Russell 2000 Growth Ishares ETF|
|Russell 2000 Growth Vanguard|
|S&P Total US Stock Market Ishares Core ETF|
|3rd Resistance Point||1.8933|
|2nd Resistance Point||1.8567|
|1st Resistance Point||1.8033|
|1st Support Level||1.7133|
|2nd Support Level||1.6767|
|3rd Support Level||1.6233|